Sotatercept | Interleukin Related interleukin-related.com

Product Name :
Sotatercept

Search keywords :
PAH

drugId :
null

Target Vo:
Activins

Target Vo Short Name :
Activins

Moa_Name:
Osteogenesis stimulants

First Approval Country :
United States

First Approval Date Filter:
2024

Origin Company_Name :
Acceleron Pharma Inc

Active Company_Name :
Acceleron Pharma Inc

Active Indication_Name:
Pulmonary Arterial Hypertension

In Active Indication_Name:
beta-Thalassemia

Termination Status :

China Termination Status :

Highest Status:
Approved

China Highest Status:
Phase 1 Clinical

Antibodies are immunoglobulins secreted by effector lymphoid B cells into the bloodstream. Antibodies consist of two light peptide chains and two heavy peptide chains that are linked to each other by disulfide bonds to form a “Y” shaped structure. Both tips of the “Y” structure contain binding sites for a specific antigen. Antibodies are commonly used in medical research, pharmacological research, laboratory research, and health and epidemiological research. They play an important role in hot research areas such as targeted drug development, in vitro diagnostic assays, characterization of signaling pathways, detection of protein expression levels, and identification of candidate biomarkers.
Related websites: https://www.medchemexpress.com/antibodies.html
Popular product recommendations:
Phospho-FOXO3A (Ser253) Antibody
EGR1 Antibody
Phospho-AMPK alpha 1 (Ser496) Antibody: Phospho-AMPK alpha 1 (Ser496) Antibody is a non-conjugated and Rabbit origined polyclonal antibody about 64 kDa, targeting to Phospho-AMPK alpha 1 (Ser496). It can be used for WB,IHC-P,ICC/IF assays with tag free, in the background of Human, Mouse, Rat.

Author: Interleukin Related

Related Posts